Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1.0 mg vs 2.0 mg Alteplase for Hemodialysis Catheter Occlusion
NCT02225782Unknown
- Sponsor
- University of Windsor
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial of tissue-plasminogen activator in catheter occlusion, sponsored by University of Windsor. Primary endpoint: Restoration of hemodialysis catheter function at 30 minutes. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
catheter occlusion
Beyond the preview
Go deeper on NCT02225782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02225782.